These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1555627)

  • 1. Rate-dependent failure of ventricular capture in patients treated with oral propafenone.
    Soriano J; Almendral J; Arenal A; San Román D; Delcan JL; Josephson ME
    Eur Heart J; 1992 Feb; 13(2):269-74. PubMed ID: 1555627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
    Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M; Beermann J; Gerckens U; Lüderitz B
    Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time.
    Kus T; Dubuc M; Lambert C; Shenasa M
    J Am Coll Cardiol; 1990 Nov; 16(5):1229-37. PubMed ID: 2229772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
    Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
    Stark U; Stark G; Kasper K; Schwarzl I; Decrinis M; Pilger E; Tritthart HA
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
    Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
    J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of propafenone for supraventricular arrhythmias in infants and children.
    Janousek J; Paul T; Reimer A; Kallfelz HC
    Am J Cardiol; 1993 Aug; 72(3):294-300. PubMed ID: 8342507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
    Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA
    Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation].
    Fauchier JP; Cosnay P; Moquet B; Rouesnel P; Kapusta P; Vrancea F
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1506-14. PubMed ID: 3099684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
    Montenero AS; Natale A; di Bona G; Calvi V; Santarelli P; Manzoli U
    Cardiologia; 1990 Mar; 35(3):253-6. PubMed ID: 2123130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propafenone in the prevention of non-ventricular arrhythmias associated with the Wolff-Parkinson-White syndrome.
    Vassiliadis I; Papoutsakis P; Kallikazaros I; Stefanadis C
    Int J Cardiol; 1990 Apr; 27(1):63-70. PubMed ID: 2335410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propafenone in Wolff-Parkinson-White syndrome at risk.
    Santinelli V; Turco P; De Paola M; Smimmo D; Giasi M; Santinelli C; Chiariello M; Condorelli M
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):681-5. PubMed ID: 2076378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias.
    Budde T; Borggrefe M; Podczeck A; Martinez-Rubio A; Breithardt G
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):254-60. PubMed ID: 1717787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiologic effects of intravenous propafenone].
    Zhang S; Sun RL; Song YC
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Jun; 17(3):133-6, 189. PubMed ID: 2598779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V; Mewis C; Mayer F; Seipel L
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of ventricular arrhythmias with propafenone].
    Petri H; Kafka W; Rudolph W
    Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of propafenone in supraventricular arrhythmias].
    Kauffmann R; Goich J; Parra C; Ayala A; Manzur F
    Rev Med Chil; 1989 Apr; 117(4):401-5. PubMed ID: 2519393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute effects of propafenone in patients with ventricular pre-excitation].
    Maia IG; Cruz Filho F; Fagundes ML; Loyola LH; Pimenta J; Lorga AM
    Arq Bras Cardiol; 1993 Jul; 61(1):23-6. PubMed ID: 8285860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.